Feed Preview

Alzheimer's Disease: RNA Regulation

Alzheimer's Disease: RNA Regulation diagram by NIH (Public Domain)
NIH (Public Domain)

RNA regulation involves several mechanisms that are used by cells to decreases or increase the production of RNA. Issues with RNA regulation are associated with Alzheimer's Disease (AD). Here are the latest discoveries pertaining to RNA regulation and this disease.

Top 20 most recent papers
Nature Medicine

Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report

Nature MedicineNovember 4, 2019
Joseph F Arboleda-VelasquezYakeel T Quiroz
3116
255
9
2
bioRxiv

Natural cryptic epigenetic variation in an embryonic gene regulatory network

bioRxivNovember 5, 2019
Chee Kiang EweJoel H Rothman
16
The EMBO Journal

RNA toxicity in non-coding repeat expansion disorders

The EMBO JournalNovember 13, 2019
Bart SwinnenLudo Van Den Bosch
bioRxiv

Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer's Disease

bioRxivNovember 7, 2019
How-Wing LeungAntonius M J VanDongen
5
Scientific Reports

Ageing and amyloidosis underlie the molecular and pathological alterations of tau in a mouse model of familial Alzheimer's disease

Scientific ReportsOctober 31, 2019
Athanasios MetaxasBente Finsen
1
1
Journal of Toxicology and Environmental Health. Part a

Differentially expressed long-chain noncoding RNAs in human neuroblastoma cell line (SH-SY5Y): Alzheimer's disease cell model

Journal of Toxicology and Environmental Health. Part aNovember 13, 2019
Ming ZhangZhi-Ying Zhao
EMBO Molecular Medicine

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

EMBO Molecular MedicineNovember 11, 2019
Sebastian PalmqvistOskar Hansson
11
International Journal of Molecular Sciences

Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study

International Journal of Molecular SciencesOctober 30, 2019
Zoya O SerebrovskaVictor E Dosenko
3
International Journal of Molecular Sciences

Exploring the Regulatory Role of Circular RNAs in Neurodegenerative Disorders

International Journal of Molecular SciencesNovember 4, 2019
Eleonora D'AmbraMariangela Morlando
The International Journal of Neuroscience

LncRNA Rpph1 Protects Amyloid-β Induced Neuronal Injury in SK-N-SH Cells via miR-122/Wnt1 Axis

The International Journal of NeuroscienceNovember 13, 2019
Ran GuXiao Hu
Neurotoxicity Research

Common Variant in TREM1 Influencing Brain Amyloid Deposition in Mild Cognitive Impairment and Alzheimer's Disease

Neurotoxicity ResearchNovember 13, 2019
Yue-Song LiuAlzheimer’s Disease Neuroimaging Initiative
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

Measuring longitudinal cognition: Individual tests versus composites

Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringNovember 2, 2019
Erin McMullen JonaitisSterling C. Johnson
3
1
21
Science Advances

Low-complexity domain of U1-70K modulates phase separation and aggregation through distinctive basic-acidic motifs

Science AdvancesNovember 1, 2019
Song XueShi-Zhong Luo
Chemosphere

Knockdown of TNFAIP1 prevents di-(2-ethylhexyl) phthalate-induced neurotoxicity by activating CREB pathway

ChemosphereOctober 14, 2019
Feng QiuShuang-lin Xiang
Journal of Alzheimer's Disease : JAD

Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker

Journal of Alzheimer's Disease : JADOctober 29, 2019
Federico MassaLucilla Parnetti
Life Sciences

Amentoflavone suppresses Amyloid β1-42 neurotoxicity in Alzheimer's disease through the inhibition of pyroptosis

Life SciencesNovember 10, 2019
Ning-Ning ZhaoRan Shi
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics

Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeuticsOctober 30, 2019
Jie Jiang, John M Ravits
1
Journal of Alzheimer's Disease : JAD

Gottfries' Cognitive Scale for Staff Proxy Rating of Cognitive Function Among Nursing Home Residents

Journal of Alzheimer's Disease : JADOctober 29, 2019
Hugo LövheimPer-Olof Sandman
1
Journal of Alzheimer's Disease : JAD

Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease

Journal of Alzheimer's Disease : JADOctober 29, 2019
Karol DowjatYu-Wen Hwang
1
Journal of Alzheimer's Disease : JAD

Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease

Journal of Alzheimer's Disease : JADOctober 29, 2019
Ana PozuetaPascual Sánchez-Juan
10
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2019 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-regulation/cf295a8b-d130-4ba5-9e4e-222d91a713df